Download App
Help CenterSubscribe
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

Brabourne Enterprises Ltd. (Amalgamated) (BRABOURNE)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 500384 NSE: BRABOURNE Pharmaceuticals & Drugs | Small Cap | Brabourne Enter Share Price

BSE Share Price
Not Listed

Brabourne Enterprises Ltd. (Amalgamated) (BRABOURNE)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 500384 NSE: BRABOURNE Pharmaceuticals & Drugs | Small Cap | Brabourne Enter Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹15 Cr.
Current Price
₹0
52-Week Low / High
₹10 / 10
TTM EPS
₹1.4
TTM Sales
₹6.5 Cr.
Book Value per Share
₹45.1
P/E Ratio
7.26
Industry PE
54.2
Price to Book (P/B)
0.22
Price to Sales (P/S)
2.25
EV/EBITDA
2.01
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
-44.37%
Return on Capital Employed (ROCE)
-24.19%
Return on Assets (ROA)
-22.73%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Steady versus 3-year growth rate
-100%
Operating Profit Growth (1 Year)
-
-100.58%
Net Profit Growth (1 Year)
-
-460.46%
Asset Quality
Promoter Holding
43.71%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹50 Cr.
Equity
₹14.4 Cr.
Face Value
₹10
All Time Low / High
₹4.55 / 206.95

Brabourne Enterprises . (Amalgamated) stock performance

Key Ratios
mw4me loader

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation ⓘ

Mar'98Mar'99Mar'00Sep'01Mar'03Mar'04Mar'05Mar'06Mar'07Mar'08TTM
ROCE % ⓘ11.1%14.8%14.2%15.5%-4.4%5.5%7.1%21.8%11.9%-22.8%-

Growth Parameters ⓘ
Sales ⓘ18621318118510711912414512100
Sales YoY Gr.-14.7%-15.1%2.1%-42.2%11.8%4.1%16.6%-16.5%-100%-
Adj EPS ⓘ4.98.67.43.2-8.2-5.3-3.413.85.9-7.8-0.1
YoY Gr.-76.4%-14.3%-56.1%-354.5%NANANA-57.2%-232.4%-
BVPS (₹) ⓘ83.281.278.752.832.945.932.859.763.843.443.3
Adj Net
Profit ⓘ		5.39.49.14-10.2-6.6-4.219.88.5-11.2-0
Cash Flow from Ops. ⓘ-7.5-11.40.220.439.632.722.544.415.30.1-
Debt/CF from Ops. ⓘ-12.1-9.7570.85.42.53.95.32.15.50-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘ-100%-100%-100%-100%
Adj EPS ⓘ-205.4%NANA-232.4%
BVPSⓘ-7%5.7%9.8%-31.9%
Share Price - - - -

Key Financial Parameters ⓘ

Mar'98Mar'99Mar'00Sep'01Mar'03Mar'04Mar'05Mar'06Mar'07Mar'08TTM
Return on
Equity % ⓘ		5.810.29.45.9-18-10.6-8.530.99.4-14.5-0.1
Op. Profit
Mgn % ⓘ		8.111.813.112.82.712.29.327.419.40NAN
Net Profit
Mgn % ⓘ		2.94.45.12.2-9.6-5.5-3.413.670-INF
Debt to
Equity ⓘ		11.21.41.72.42.22.91.10.90-
Working Cap
Days ⓘ		019027421036141838132839100
Cash Conv.
Cycle ⓘ		0711026777224-42-1800

Valuation of Brabourne Enter - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Financials

PARTICULARSMar'03Mar'04Mar'05Mar'06Mar'07Mar'08
Sales163.44119.48126.46145.04120.350
Operating Expenses ⓘ + 159.09108.20114.35106.0298.040.13
Manufacturing Costs16.3417.4520.4210.4211.150
Material Costs63.3042.8543.3143.1041.340
Employee Cost 27.4317.8319.5719.4020.580.04
Other Costs ⓘ 52.0230.0831.0533.1024.970.09
Operating Profit ⓘ 4.3511.2812.1139.0222.31-0.13
Operating Profit Margin (%) 2.7%9.4%9.6%26.9%18.5%-
Other Income ⓘ + 8.387.175.2614.953.970.53
Exceptional Items ⓘ -15.270000-27.17
Interest ⓘ 38.4925.3522.4219.9811.570.08
Depreciation ⓘ 8.277.124.695.594.760
Profit Before Tax ⓘ -49.30-14.02-9.7428.419.94-26.84
Tax ⓘ -12.29-2.0702.671.682.97
Profit After Tax -37.01-11.95-9.7425.748.27-29.81
PAT Margin (%) -22.7%-10.0%-7.7%17.8%6.9%-
Adjusted EPS (₹)-29.8-9.6-7.817.95.8-20.8
Dividend Payout Ratio (%)0%0%0%14%26.10%0%
PARTICULARSMar'03Mar'04Mar'05Mar'06Mar'07Mar'08

Equity and Liabilities

Shareholders Fund + 50.1336.7815.0665.8271.5762.85
Share Capital ⓘ 12.4512.4512.4514.3914.3914.39
Reserves ⓘ 37.6824.332.6151.4457.1848.46
Debt +185.29165.01156.4497.1984.881.08
Long Term Debt185.29165.01156.4497.1984.881.08
Short Term Debt000000
Minority Interest000000.27
Trade Payables32.4733.7137.5037.9430.930.01
Others Liabilities ⓘ 12.1917.8126.2218.499.541.16
Total Liabilities ⓘ 280.09253.31235.23219.44196.9265.37

Fixed Assets

Net Fixed Assets ⓘ +53.6945.7442.2642.1038.590.99
Gross Block87.1685.9887.1492.5893.471.42
Accumulated Depreciation33.4740.2444.8950.4754.880.43
CWIP ⓘ 2.091.801.710.1311.970
Investments ⓘ 142.48135.59134.4894.9089.8453.41
Inventories24.7225.5027.7923.3419.270
Trade Receivables34.8224.9122.5125.4324.420
Cash Equivalents 1.961.060.7027.298.190.42
Others Assets ⓘ 20.3218.725.796.244.6310.55
Total Assets ⓘ 280.09253.31235.23219.44196.9265.37
PARTICULARSMar'03Mar'04Mar'05Mar'06Mar'07Mar'08
Cash Flow From Operating Activity ⓘ + 56.7532.5922.4743.7815.320.11
PBT ⓘ -31.20-14.02-9.7428.419.94-26.85
Adjustment ⓘ 46.1332.4927.5116.091526.71
Changes in Working Capital ⓘ 48.6313.518.94.36-9.380.3
Tax Paid ⓘ -0.100.53-4.21-5.09-0.24-0.05
Cash Flow From Investing Activity ⓘ + 6.817.133.4048.71-6.210.42
Capex 25.551.95-1.33-4.52-13.230
Net Investments -34.605.361.1150.565.070
Others ⓘ 15.86-0.183.622.671.960.42
Cash Flow From Financing Activity ⓘ + -67.06-39.62-26.21-65.81-28.21-2.76
Net Proceeds from Shares ⓘ 00030.6500
Net Proceeds from Borrowing ⓘ 13.22-16.38-13.61-61.73-19.200
Interest Paid ⓘ -30.95-20.60-16.22-36.11-12.950
Dividend Paid ⓘ -2.98000-4.10-2.52
Others ⓘ -46.34-2.643.621.388.03-0.24
Net Cash Flow ⓘ -3.500.10-0.3426.67-19.10-2.22
PARTICULARSMar'03Mar'04Mar'05Mar'06Mar'07Mar'08
Ratios
ROE (%)-77.36-28.71-39.0264.2212.05-44.37
ROCE (%)-4.645.236.8328.9113.39-24.19
Asset Turnover Ratio0.640.490.560.70.620
PAT to CFO Conversion(x)N/AN/AN/A1.71.85N/A
Working Capital Days
Receivable Days70.9082.8062.8055.2070.300
Inventory Days50.3069.6070.6058.9060.100
Payable Days179.80273.90291.80306.90291.800

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Brabourne Enterprises Ltd. (Amalgamated) FAQs

The current trading price of Brabourne Enter on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Brabourne Enter stood at ₹14.58 Cr

The latest P/E ratio of Brabourne Enter as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Brabourne Enter as of 31-Dec-1969 is 0.23.

The 52-week high of Brabourne Enter is ₹10.40 and the 52-week low is ₹9.60.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Brabourne Enter is ₹0.00 ( Cr.) .

Data is not available for this company.

No data found

No data found

About Brabourne Enterprises Ltd. (Amalgamated)

Brabourne Enterprises Ltd the demerged arm of RPG life was incorporated on May 12, 1967. The entire pharmaceuticals business of the Company has been sold to RPG Life Sciences Ltd. (formerly RPG Pharmaceuticals Ltd.) with effect from April 2, 2007 on going concern basis along with all assets and liabilities pertaining to the said business, at consideration of Rs. 46 crore. Thus, the results and revenue of the pharmaceutical business from April 2, 2007 has become revenue and results of RPG Pharmaceuticals Ltd. The unaudited financial results of the company for 9 months ended December 31, 2007, which pertains to the pharmaceutical business. The Group operates in two segments, namely, Pharmaceuticals and Investments and lending.

The entire Investments held by the company (excluding US 64 bonds) stands sold to Instant Holdings Ltd effective from April 1, 2007, at a consideration of Rs 53 crore. Instant Trading and Investment Company Ltd is a wholly owned subsidiary of RPG Life Sciences Ltd. RPG Pharmaceuticals Ltd and Instant Holdings Ltd were incorporated on March 29, 2007 to participate in the Scheme of Arrangement.

The assets and liabilities of the Instant Trading and Investment Company Ltd were transferred to Instant Holdings Ltd and Instant Trading and Investment Company Ltd stands dissolved without winding up. Then only the company changed its name to ‘Brabourne Enterprises Ltd’ and RPG Pharmaceuticals Ltd changed its name to ‘RPG Life Sciences Ltd’.

The plants of Brabourne Enterprises are located at Gujarat and Maharashtra. 

Business area of the company:

The Company is engaged in manufacture of active pharmaceutical ingredients, both synthetic and fermentation, contract API and formulation development business with a niche product portfolio, both in chronic and acute therapy areas.

You have 47 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now